ARGX Overview
Upcoming Projects (ARGX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ARGX)
-
A Second Look: Discussing FcRn and CD19 as a target in primary immune thrombocytopenia (ITP)
Tickers: ARGX, AMGN, ELYM
Executed On: Aug 29, 2024 at 12:30 PM EDT -
Discussing FcRn and CD19 as a target in primary immune thrombocytopenia (ITP)
Tickers: ARGX, AMGN, ELYM
Executed On: Aug 28, 2024 at 01:00 PM EDT -
Discussing Argenx SE's Vyvgart Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with a focus on the data presented at the 2024 American Association of Neurology Meeting
Ticker: ARGX
Executed On: May 03, 2024 at 10:00 AM EDT -
A Second Take: Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.
Tickers: HZNP, VRDN, IMVT, ARGX
Executed On: Sep 19, 2023 at 09:45 AM EDT -
Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.
Tickers: HZNP, VRDN, IMVT, ARGX
Executed On: Sep 18, 2023 at 07:30 PM EDT -
A discussion of novel therapeutics in CIDP with a focus on Argenx' efgartigimod
Ticker: ARGX
Executed On: Nov 29, 2022 at 05:15 PM EST -
A Second Perspective: Discussing primary ITP and the potential of VYVGART (efgartigimod)
Ticker: ARGX
Executed On: Aug 22, 2022 at 11:00 AM EDT -
Discussing primary ITP and the potential of VYVGART (efgartigimod)
Ticker: ARGX
Executed On: Aug 09, 2022 at 02:00 PM EDT -
Examining the potential of VYVGART (efgartigimod alfa-fcab), the recently approved agent from Argenx, in treating Myasthenia Gravis
Ticker: ARGX
Executed On: Mar 11, 2022 at 10:00 AM EST
Expired Projects (ARGX)
-
A third Look: Discussing FcRn and CD19 as a target in primary immune thrombocytopenia (ITP)
Tickers: AMGN, ARGX, ELYM
Execute By: Sep 19, 2024
Upcoming & Overdue Catalysts (ARGX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ARGX)
-
Argenx (ARGX) reports topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia
Ticker: ARGX
Occurred on: Sep 17, 2018
Strategic Initiatives (ARGX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
